27. Deutscher Krebskongress
Deutsche Krebsgesellschaft e. V.
22. - 26.03.2006, Berlin
New Drugs in Oncology / New Diagnosis and Modalities in Cancer Therapy
Meeting Abstract
(OP430)
[Volltext]
Inhibition of Heat-shock Protein 90 (Hsp90) with 17DMAG impairs multiple angiogenic signaling pathways in gastric cancers cells in vitro and reduces tumor growth and angiogenesis in vivo
Stöltzing O, Lang S, Klein D, Bolder U, Obed A, Gaumann A, Schlitt HJ, Geissler E[Volltext]
Meeting Abstract
(OP431)
[Volltext]
Novel Titanocene Anti-Cancer Drugs
Tacke M, Strohfeldt K, Pampillón C, Sweeney N[Volltext]
Meeting Abstract
(OP432)
[Volltext]
Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein
Krauss J, Arndt MAE, Vu BK, Martin ACR, Liu H, Newton DL, Seeber S, Rybak SM, Krauss J[Volltext]
Meeting Abstract
(OP433)
[Volltext]
RAB38 represents a new target antigen for immunotherapy approaches in melanoma
Jäger D, Zippelius A, Jochims C, Knuth A[Volltext]
Meeting Abstract
(OP434)
[Volltext]
Pharmacokinetic Study of the Humanized Anti-EGF-Receptor Monoclonal Antibody Nimotuzumab in Patients (Pts) with Locally Advanced or Metastatic Pancreatic Cancer (PC)
Hilger RA, Krauss J, Scheulen ME, Bach F, Strumberg D[Volltext]
Meeting Abstract
(OP435)
[Volltext]
Influence of p21 and p53 on HDAC-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo
Ocker M, Zopf S, Neureiter D, Ganslmayer M, Hahn EG, Herold C[Volltext]
Meeting Abstract
(OP436)
[Volltext]
Hemmung des Wachstums spontaner Magenkarzinome durch den mTOR-Inhibitior Rapamycin im transgenen Tiermodell
Schwarz B, Guba M, Schroeferl S, Ischenko I, Zimmermann W, Heeschen C, Jauch KW, Bruns CJ[Volltext]
Meeting Abstract
(OP437)
[Volltext]
Growth Inhibition of Solid Tumors by Intravenous Application of cG250-TNF
Bauer S, Oosterwijk E, Stenner F, Kleber S, Pfreundschuh M, Scott A, Ritter G, Old L, Renner C[Volltext]
Meeting Abstract
(OP438)
[Volltext]
Effective tumor therapy with coagulation active Antithrombin III in a human pancreatic cancer xenograft model in SCID mice
Celik I, Dietz C, Sürücü O, Karakas E, Kalina U, Kisker O[Volltext]
Meeting Abstract
(OP439)
[Volltext]
Thermotherapy using magnetic nanoparticles, a new approach in cancer therapy
Jordan A, Wust P, Maier-Hauff K, Johannsen M, Scholz R, Gneveckow U, Thiesen B, Waldöfner N, Felix R[Volltext]
Meeting Abstract
(OP440)
[Volltext]
Tie2/tk transfected Mesenchymal Stem Cells for a combined Stem Cell/Suicide Gene Therapy of Pancreatic Carcinoma
Conrad C, Bruns C, Niess H, Huss R, von Teichert-Lüttichau I, Mojaat A, Jauch KW, Nelson P[Volltext]
Meeting Abstract
(OP441)
[Volltext]
A Clinical Phase I Study of the Triple Angiokinase Inhibitor BIBF 1120 in Advanced Cancer Patients
Mross K, Frost A, Gmehling D, Bass F, Unger C, Strecker R, Hennig J, Deichsel G, Stefanic M, Stopfer P, de Rossi L[Volltext]
Meeting Abstract
(PO442)
[Volltext]
Enzastaurin: Correlations of Chemosensitivity and Gene Expression in Human Solid Tumors
Eismann U, Oberschmidt O, Ehnert M, Fleeth J, Lüdtke FE, Struck S, Schulz L, Blatter J, Lahn MM, Ma D, Hanauske AR[Volltext]
Meeting Abstract
(PO443)
[Volltext]
Pemetrexed Combined with Paclitaxel: A Phase I Trial in Advanced Solid Tumors
Graefe T, Bolling C, Lübbing C, Yilmaz E, Müller-Hagen S, Leisner B, Blatter J, Hanauske AR[Volltext]
Meeting Abstract
(PO444)
[Volltext]
Molecular characterization of the anti-idiotypic immune response of a relapse-free neuroblastoma patient following antibody therapy. A possible vaccine against tumors of neuroectodermal origin?
Fischer P, Krueger J, Uttenreuther-Fischer MM[Volltext]
Meeting Abstract
(PO445)
[Volltext]
Combined treatment of colorectal tumors with apoptosis inducing TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: Additive effects in vitro and in vivo
Marini P, Kauder S, Schiller D, Denzinger S, Welz S, Jendrossek V, Budach W, Belka C[Volltext]
Meeting Abstract
(PO446)
[Volltext]
Antitumoral activity of the novel antitumoral compound CLU-502, isolated from Clusia rosea, in neuroblastoma and leukemia cell lines
Diaz-Carballo D, Hilger RA, Malak S, Strumberg D, Seeber S[Volltext]
Meeting Abstract
(PO447)
[Volltext]
Anti-angiogenesis Treatment with PTK/ZK in Ovarian Cancer: A Phase IB, Open Label, Safety and Pharmacokinetics (PK) Study of Escalating Doses of PTK787/ZK 222584 (PTK/ZK) in Combination With Paclitaxel and Carboplatin in Patients (pts) With Stage IC to IV Epithelial Ovarian Cancer
Schröder W, Abadie S, Witteveen PO, Campone M, Viens P, Jalava T, Masson E, Bilic S, Laurent D, du Bois A[Volltext]
Meeting Abstract
(PO448)
[Volltext]
Phase I study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumors
Lübbing C, Yilmaz E, Graefe T, Bolling C, Depenbrock H, Ohnmacht U, Müller-Hagen S, Hanauske AR[Volltext]
Meeting Abstract
(PO449)
[Volltext]
Syntheses of Substituted 4-(Indol-3-yl)quinazolines, a New Class of EGFR-Tyrosinkinase Inhibitors
Lüth A, Löwe W, Luger P, Weber M[Volltext]
Meeting Abstract
(PO450)
[Volltext]
Imaging controlled cancer therapy with magnetic nanoparticles
Alexiou C, Schick B, Jurgons R, Seliger C, Trahms L, Odenbach S, Iro H[Volltext]
Meeting Abstract
(PO451)
[Volltext]
Phase I trial of sorafenib (BAY 43-9006) combined with dacarbazine (DTIC) in patients with metastatic melanoma
Eisen T, Ahmad T, Marais R, Gibbens I, James M, Affolter A, Chao D, Bergamini L, Schwartz B, Gore ME[Volltext]
Meeting Abstract
(PO452)
[Volltext]
Erucylphosphocholine and erucylphosphohomocholine increase sensitivity of human malignant glioma cell lines to the cytotoxic effects of ionizing radiation
Rübel A, Handrick R, Eibl H, Budach W, Belka C, Jendrossek V[Volltext]
Meeting Abstract
(PO453)
[Volltext]
Enzastaurin, a Novel PKC-β Inhibitor, Inhibits Growth of Freshly Explanted Human Tumor Cells
Oberschmidt O, Eismann U, Ehnert M, Fleeth J, Lüdtke FE, Struck S, Schulz L, Blatter J, Lahn MM, Ma D, Hanauske AR[Volltext]
Meeting Abstract
(PO454)
[Volltext]
Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo
Michaelis M, Fichtner I, Haider W, Rothweiler F, Cinatl J, Mack A, Doerr HW, Cinatl jr. J[Volltext]
Meeting Abstract
(PO455)
[Volltext]
The Effect of Src Kinase Inhibition on 5-Fluorouracil Chemosensitivity Is Related to Thymidylate Synthase Expression in Human Pancreatic Carcinoma Cells
Ischenko I, Camaj P, Guba M, Brückel M, de Toni E, Graeb C, Jauch KW, Bruns C[Volltext]
Meeting Abstract
(PO456)
[Volltext]
Endostatin - albumin fusion protein improves in vitro and in vivo effectiveness in tumor therapy
Celik I, Dietz C, Sürücü O, Mertins P, Kisker O[Volltext]
Meeting Abstract
(PO457)
[Volltext]
Efficacy of CXCR2 inhibition on tumor angiogenesis in pancreatic cancer
Albrecht U, Schwarz B, Schroeferl S, Schmid G, Baumann C, Ischenko I, Guba M, Heeschen C, Jauch KW, Bruns CJ[Volltext]
Meeting Abstract
(PO458)
[Volltext]
Clinical phase I study of a (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH) in patients with advanced cancers
Unger C, Medinger M, Steinbild S, Drevs J, Häring B, Kratz F, Mross K[Volltext]
Meeting Abstract
(PO459)
[Volltext]
First patients with NF1 and malignant peripheral nerve sheath tumors treated with imantinib. Start of an open labelled phase II study
Mautner VF, Holtkamp N, Straeter R, Tatagiba M, Friedrich R, de Wit M[Volltext]
Meeting Abstract
(PO460)
[Volltext]
Taxol inhibits significantly an experimentally induced peritoneal carcinomatosis depending on the application mode
Hribaschek A, Meyer F, Pross M, Ridwelski K, Küster D, Lippert H[Volltext]
Meeting Abstract
(PO461)
[Volltext]
Bortezomib (VELCADE®, VEL) in the treatment of multiple myeloma (MM) – a prospective, non-interventional scientific study in office-based hematologists (OBH)
Knauf W, Otremba B, Overkamp F, Bammer S, Angermund R[Volltext]
Meeting Abstract
(PE462)
[Volltext]
The treatment of brain cancer with Drug-Nanoparticle complex
Singh S, Singh S, Bouazzaoui A, Kubasch J, Radunz HE, Sabel BA[Volltext]
Meeting Abstract
(PE463)
[Volltext]
Immunotherapeutic options in gastric cancer
Illert B, Meyer D, Thiede A[Volltext]
Meeting Abstract
(PE464)
[Volltext]
Selenium – A Novel Radiosensitizer?
Schüller P, Püttmann S, Micke O[Volltext]
Meeting Abstract
(PE465)
[Volltext]
Target selective activation of a TNF prodrug by urokinase type plasminogen activator (uPA) mediated proteolytic processing at the cell surface
Gerspach J, Nemeth J, Münkel S, Wajant H, Pfizenmaier K[Volltext]
Meeting Abstract
(PE466)
[Volltext]
Single-chain Fv immunoliposomes for drug delivery in cancer therapy
Kontermann R, Müller D, Baum P, Trunk G, Höfig I, Zettlitz K[Volltext]
